Bayer Aktiengesellschaft (BAYZF)

Market Cap	38.06B
Revenue (ttm)	53.81B
Net Income (ttm)	-232.31M
Shares Out	n/a
EPS (ttm)	-0.24
PE Ratio	n/a
Forward PE	7.01
Dividend	0.13 (0.32%)
Ex-Dividend Date	Apr 28, 2025

Volume	1,650
Average Volume	1,378
Open	39.28
Previous Close	39.79
Day's Range	38.70 - 39.28
52-Week Range	19.50 - 40.18
Beta	0.83
RSI	70.62
Earnings Date	Nov 12, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1863
• Employees: 91,864
• Stock Exchange: OTCMKTS
• Ticker Symbol: BAYZF

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR